Issue 3/2016

Current trends in the treatment of malignant melanoma (333 — 341)

M. VALKO-ROKYTOVSKA, K. BRUCHATA, J. SIMKOVA, M. MILKOVICOVA, Z. KOSTECKA

DOI: 10.4149/301_151015N533

A new hope: the immunotherapy in small cell lung cancer (342 — 350)

Q. LI, D. YUAN, C. MA, Y. LIU, L. MA, T. LV, Y. SONG

DOI: 10.4149/302_151001N511

Physcion 8-O-β-glucopyranoside prevents hypoxia-induced epithelial-mesenchymal transition in colorectal cancer HCT116 cells by modulating EMMPRIN (351 — 361)

Z. DING, F. XU, J. TANG, G. LI, P. JIANG, Z. TANG, H. WU

DOI: 10.4149/303_150723N405

Reversal of cisplatin resistance by inhibiting PI3K/Akt signal pathway in human lung cancer cells (362 — 370)

Y. ZHANG, C. BAO, Q. MU, J. CHEN, J. WANG, Y. MI, A. J. SAYARI, Y. CHEN, M. GUO

DOI: 10.4149/304_150806N433

Expression of ARE-binding proteins AUF1 and HuR in follicular adenoma and carcinoma of thyroid gland (371 — 377)

B. TROJANOWICZ, C. SEKULLA, H. DRALLE, C. HOANG-VU

DOI: 10.4149/305_150819N450

OCT4 is up-regulated by DNA hypomethylation of promoter in recurrent gliomas (378 — 384)

Y. WU, B. SUN, W. SHI, L. NI, J. CHEN, G. CAI, J. SHI

DOI: 10.4149/306_150919N492

Overexpression of BTG2 suppresses growth, migration, and invasion of human renal carcinoma cells in vitro (385 — 393)

JIN SIMA, B. ZHANG, X. Y. SIMA, Y. X. MAO

DOI: 10.4149/307_150822N455

RNA-Seq analysis for the potential targets and molecular mechanisms of 17 β-estradiol in squamous cell lung carcinoma (394 — 401)

X. CHEN, R. WU, S. WANG, Q. DUAN, Y. XUAN

DOI: 10.4149/308_150814N445

Genome-wide methylation analysis of tubulocystic and papillary renal cell carcinomas (402 — 410)

M. KORABECNA, J. GERYK, M. HORA, P. STEINER, O. SEDA, V. TESAR

DOI: 10.4149/309_151102N559

Uc.206 regulates cell proliferation and apoptosis by targeting P53 in cervical cancer cells (411 — 418)

Q. LI, X. LI, C. WANG

DOI: 10.4149/310_151017N538

Serum SOX11 promoter methylation is a novel biomarker for the diagnosis of Hepatitis B virus-related hepatocellular carcinoma (419 — 426)

Y. TENG, Y. C. FAN, N. N. MU, J. ZHAO, F. K. SUN, K. WANG

DOI: 10.4149/311_151029N552

Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes (427 — 434)

K. POHLODEK, S. BOZIKOVA, I. MECIAROVA, V. MUCHA, M. BARTOVA, F. ONDRIAS

DOI: 10.4149/312_150922N497

The prognostic significance of epidermal growth factor receptor expression in patients with anal carcinoma (435 — 441)

I. RICHTER, T. JIRASEK, J. DVORAK, E. CERMAKOVA, J. BARTOS

DOI: 10.4149/313_150913N485

Aberrant expression of long noncoding RNA PVT1 and its diagnostic and prognostic significance in patients with gastric cancer (442 — 449)

C. L. YUAN, H. LI, L. ZHU, Z. LIU, J. ZHOU, Y. SHU

DOI: 10.4149/314_150825N45

The effectiveness of chemotherapy and electrochemotherapy on ovarian cell lines in vitro (450 — 455)

J. SACZKO, J. PILAT, A. CHOROMANSKA, N. REMBIALKOWSKA, J. BAR, I. KAMINSKA, J. ZALEWSKI, J. KULBACKA

DOI: 10.4149/315_150930N510

Treatment and prognosis of childhood acute lymphoblastic leukemia on protocols ALL-BFM 90, 95 and ALL IC-BFM 2002: a retrospective single-center study from Olomouc, Czech Republic (456 — 461)

J. VOLEJNIKOVA, M. JAROSOVA, D. POSPISILOVA, Z. NOVAK, J. VRBKOVA, M. HAJDUCH, V. MIHAL

DOI: 10.4149/316_150910N482

NF-κB/p65 expression before and after treatment in rectal cancer patients undergoing neoadjuvant (chemo)radiotherapy and surgery: prognostic marker for disease progression and survival (462 — 470)

R. VOBORIL, V. RYCHTEROVA, J. VOBORILOVA, M. KUBECOVA, J. FANTA, J. DVORAK

DOI: 10.4149/317_151013N525

Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib (471 — 476)

O. FIALA, M. PESEK, J. FINEK, J. RACEK, M. MINARIK, L. BENESOVA, Z. BORTLICEK, O. SOREJS, R. KUCERA, O. TOPOLCAN

DOI: 10.4149/318_151001N512

Prognostic significance of GRP78/BiP expression in patients with Stage III/IV hypopharyngeal squamous cell carcinoma (477 — 483)

K. KAIRA, M. TOYODA, A. SHIMIZU, H. IMAI, K. SAKAKURA, O. NIKKUNI, M. SUZUKI, M. IIJIMA, T. ASAO, K. CHIKAMATSU

DOI: 10.4149/319_151002N513

Gastrointestinal stromal tumors - quantitative detection of the Ki-67, TPX2, TOP2A, and hTERT telomerase subunit mRNA levels to determine proliferation activity and a potential for aggressive biological behavior (484 — 492)

A. KALFUSOVA, I. HILSKA, L. KRSKOVA, M. KALINOVA, Z. LINKE, R. KODET

DOI: 10.4149/320_150714N390